JBS (NYSE:JBS – Get Free Report) was downgraded by JPMorgan Chase & Co. from an “overweight” rating to a “neutral” rating in a report released on Thursday, Marketbeat Ratings reports. They currently have a $18.50 price target on the stock, down from their prior price target of $20.50. JPMorgan Chase & Co.‘s price objective would suggest a potential upside of 36.96% from the company’s current price.
JBS has been the topic of a number of other reports. Weiss Ratings restated a “buy (b-)” rating on shares of JBS in a report on Monday, May 4th. UBS Group upgraded shares of JBS to a “strong-buy” rating in a report on Friday, February 6th. Zacks Research downgraded shares of JBS from a “hold” rating to a “strong sell” rating in a report on Tuesday, April 14th. Mizuho upgraded shares of JBS to a “strong-buy” rating in a report on Friday, April 10th. Finally, Barclays boosted their target price on shares of JBS from $22.00 to $23.00 and gave the stock an “overweight” rating in a report on Friday, March 27th. Two analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, JBS currently has an average rating of “Buy” and a consensus target price of $19.42.
Check Out Our Latest Analysis on JBS
JBS Stock Performance
JBS (NYSE:JBS – Get Free Report) last posted its earnings results on Tuesday, May 12th. The company reported $0.20 earnings per share for the quarter, missing analysts’ consensus estimates of $0.28 by ($0.08). JBS had a return on equity of 19.28% and a net margin of 1.98%.The business had revenue of $21.61 billion during the quarter. The business’s quarterly revenue was up 10.7% compared to the same quarter last year. As a group, analysts anticipate that JBS will post 1.93 EPS for the current fiscal year.
Hedge Funds Weigh In On JBS
A number of large investors have recently made changes to their positions in the company. Arrowstreet Capital Limited Partnership boosted its stake in shares of JBS by 117.1% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 7,687,775 shares of the company’s stock worth $138,072,000 after purchasing an additional 4,147,304 shares during the period. Sei Investments Co. boosted its position in JBS by 52.9% in the 1st quarter. Sei Investments Co. now owns 171,490 shares of the company’s stock valued at $3,080,000 after buying an additional 59,296 shares during the period. Walleye Capital LLC purchased a new stake in JBS in the 1st quarter valued at about $363,000. Cetera Investment Advisers boosted its position in JBS by 3.2% in the 1st quarter. Cetera Investment Advisers now owns 42,083 shares of the company’s stock valued at $756,000 after buying an additional 1,292 shares during the period. Finally, NewEdge Wealth LLC boosted its position in JBS by 18.5% in the 1st quarter. NewEdge Wealth LLC now owns 403,750 shares of the company’s stock valued at $7,251,000 after buying an additional 62,974 shares during the period.
Key Headlines Impacting JBS
Here are the key news stories impacting JBS this week:
- Positive Sentiment: Zacks Research upgraded JBS from strong sell to hold, suggesting the sell-off may have gone too far and that downside sentiment could be easing.
- Positive Sentiment: Barclays kept an overweight rating on JBS and assigned a new $21.00 price target, indicating meaningful upside from current levels despite trimming its prior target.
- Neutral Sentiment: JBS reported its Q1 2026 earnings call and related coverage highlighted valuation questions after recent share weakness, keeping investor focus on whether the stock is undervalued after the pullback. JBS N.V. (JBS) Q1 2026 Earnings Call Transcript
- Neutral Sentiment: Coverage from industry and market outlets pointed to tight cattle supply and broader North American headwinds weighing on results, reinforcing concerns about near-term earnings pressure. Tight cattle supply weighs on JBS earnings
- Neutral Sentiment: Valuation-focused commentary noted the recent share-price weakness, with investors reassessing whether JBS’s lower multiple reflects temporary turbulence or a deeper slowdown. Assessing JBS (NYSE:JBS) Valuation After Recent Share Price Weakness
- Negative Sentiment: JPMorgan Chase & Co. downgraded JBS to neutral from overweight, signaling less confidence in near-term upside.
- Negative Sentiment: Barclays also cut its price target from $23.00 to $21.00, showing analysts are still positive but more cautious about the earnings outlook.
- Negative Sentiment: JBS posted a 56% drop in Q1 net profit amid challenges in North American operations, a key reason investors have been selling the shares. JBS posts 56% drop in Q1 net profit amid challenges in North American operations
- Negative Sentiment: Further reporting said North American headwinds whacked profits, reinforcing concerns that operating conditions may remain difficult in the near term. JBS slips after headwinds in North America whack profits
About JBS
JBS SA is a global leader in the production and processing of meat products, with a focus on beef, pork and poultry. Headquartered in São Paulo, Brazil, the company operates through an extensive network of owned facilities and partnerships that span the Americas, Europe and the Asia-Pacific region. JBS supplies fresh, frozen and value-added protein solutions for retail, foodservice and industrial customers, and is active across the entire supply chain—from livestock procurement and feed production to slaughtering, processing, packaging and distribution.
Founded in 1953 by José Batista Sobrinho in Anápolis, Goiás, JBS began as a small slaughterhouse and expanded rapidly through strategic acquisitions and organic growth.
See Also
- Five stocks we like better than JBS
- Viking Sails to All-Time Highs—Fundamentals Signal More to Come
- Datavalut Gains Traction: 5 Reasons to Sell Now
- TMC Stock: Why This Pre-Revenue Miner Is Worth Watching
- The Power Grid Is Dying—Is It Time to Buy Its Replacement?
Receive News & Ratings for JBS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JBS and related companies with MarketBeat.com's FREE daily email newsletter.
